Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment

Journal of Clinical Epidemiology

Volumn 59, Issue 2, 2006, Pages 144-152

  Sweeting, Michael J ^a   De Angelis, Daniela ^a,b   Neal, Keith R ^c   Ramsay, Mary E ^b   Irving, William L ^c   Wright, Mark ^d   Brant, Lisa ^b   Harris, Helen E ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Disease progression; Fibrosis; Hepatitis C; Multistage model; Natural history; Recruitment bias

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; METHODOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED KINGDOM; VIRUS TRANSMISSION;

COHORT STUDIES; DISEASE PROGRESSION; GREAT BRITAIN; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; MARKOV CHAINS; PATIENT SELECTION; PROBABILITY;

EID: 30944434618     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2005.06.008     Document Type: Article

References (27)

1. G.J. Dore, A.J. Freeman, and M. Law Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings Antivir Ther 8 2003 365 372
2. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349 1997 825 832
3. F. Roudot-Thoraval, A. Bastie, and J.M. Pawlotsky Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French Survey of 6,664 patients Hepatology 26 1997 485 490
4. F. Tremolada, C. Casarin, and A. Alberti Long-term follow-up of non-A, non-B (type-C) posttransfusion hepatitis J Hepatol 16 1992 273 281
5. L.B. Seeff, Z. Buskell-Bales, and E.C. Wright Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group N Engl J Med 327 1992 1906 1911
6. H.E. Harris, M.E. Ramsay, and J. Heptonstall The HCV National Register: towards informing the natural history of hepatitis C infection in the UK J Viral Hepat 7 2000 420 427
7. L. Serfaty, J.B. Nousbaum, and M.H. Elghouzzi Prevalence, severity, and risk-factors of liver-disease in blood-donors positive in a 2nd-generation anti-hepatitis-C virus screening-test Hepatology 21 1995 725 729
8. S. Bellentani, C. Tiribelli, and G. Saccoccio Prevalence of chronic liver-disease in the general-population of northern Italy: the Dionysos study Hepatology 20 1994 1442 1449
9. D.L. Thomas, J. Astemborski, and R.M. Rai The natural history of hepatitis C virus infection: host, viral, and environmental factors JAMA 284 2000 450 456
10. Y. Benhamou, M. Bochet, and V. Di Martino Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients Hepatology 30 1999 1054 1058
11. S. Herve, G. Savoye, and G. Riachi Chronic hepatitis C with normal or abnormal aminotransferase levels: is it the same entity? Eur J Gastroenterol Hepatol 13 2001 495 500
12. H. Matsumura, M. Moriyama, and I. Goto Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C: a study of 527 patients at one establishment J Viral Hepat 7 2000 268 275
13. M. Wali, R.F. Harrison, and P.J. Gow Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C Gut 51 2002 248 252
14. T. Poynard, V. Ratziu, and F. Charlotte Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C J Hepatol 34 2001 730 739
15. S. Deuffic-Burban, T. Poynard, and A.J. Valleron Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model J Viral Hepat 9 2002 114 122
16. Q. Yi, P.P. Wang, and M. Krahn Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection J Viral Hepat 11 2004 166 174
17. A.H. Mohsen The epidemiology of hepatitis C in a UK health regional population of 5.12 million Gut 48 2001 707 713
18. M. Wright, R. Goldin, and A. Fabre Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study Gut 52 2003 574 579
19. R. Pawson, S. Rajan, G. Hazlehurst, G. Dusheiko, R. Miller, P. Hewitt, and A. Mehta Hepatitis C Lookback Programme: a single hospital experience Transfus Med 9 1999 189 193
20. K. Ishak, A. Baptista, and L. Bianchi Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
21. E. Couto, S.W. Duffy, and H.A. Ashton Probabilities of progression of aortic aneurysms: estimates and implications for screening policy J Med Screen 9 2002 40 42
22. C.H. Jackson, L.D. Sharples, and S.G. Thompson Multistate Markov models for disease progression with classification error J R Stat Soc Ser D Statistician 52 2003 193 209
23. A. Alioum, and D. Commenges MKVPCI: a computer program for Markov models with piecewise constant intensities and covariates Comput Methods Programs Biomed 64 2001 109 119
24. A.J. Freeman, G.J. Dore, and M.G. Law Estimating progression to cirrhosis in chronic hepatitis C virus infection Hepatology 34 2001 809 816
25. G.J. Dore, A.J. Freeman, and M. Law Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 17 2002 423 430
26. T.E. Wiley, M. McCarthy, and L. Breidi Impact of alcohol on the histological and clinical progression of hepatitis C infection Hepatology 28 1998 805 809
27. L.B. Seeff, F.B. Hollinger, and H.J. Alter Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a national heart, lung, and blood institute collaborative study Hepatology 33 2001 455 463